By GLP-1 StudioGLP1Consultant
← All services

Services

GLP-1 patient research & segmentation

A grounded understanding of who your patients are and what matters to them. Everything I recommend starts here: what GLP-1 patients respond to, where their pain points are, and how this community actually talks about treatment, cost, side effects, and trust.

Most GLP-1 marketing misses because it's built on assumptions about a patient population that is changing fast. Research replaces those assumptions, so acquisition, retention, and product decisions are made about the patients you really have, not the ones you imagine.

What an engagement covers

Audience segmentation

Who your patients are: segments, motivations, and where each is in their GLP-1 journey.

Pain-point mapping

The friction that drives patients away, from onboarding through refills, seen from their side.

Language & trust signals

The words patients use and the signals they look for before they'll trust a brand with their care.

Decisions, informed

Findings translated into implications for acquisition, retention, and product, not a report that sits.

Signs this is the engagement you need

How it works

How we'll work together

Every engagement is shaped around your situation: a Strategy Intensive, an ongoing advisory relationship, or on-site work. I'll find the right fit with you on a 30-minute call.

01

A 30-minute call

We talk through where you are and what you need.

02

Shaped around you

I scope the engagement, and the investment, to your situation.

03

I begin the work

A Strategy Intensive, ongoing advisory, or on-site work.

Related

Let's build something your patients can trust.

Start with a 30-minute call. If it is a good fit, I will take it from there.

Disclaimer:GLP-1 Consultant, a GLP-1 Studio LLC service, provides business strategy and operations consulting only. Nothing on this site or in the client portal is medical, clinical, legal, regulatory, tax, accounting, or investment advice. No professional-client relationship of that kind is created, and no content here is a substitute for advice from a licensed professional. Please don't submit patient or protected health information. See our Terms and Privacy Policy. GLP-1 Consultant is a service of GLP-1 Studio LLC. Bright Rowan is an independent firm owned and operated by Christie Clutter. The scope, responsibilities, contracting parties, and fees for each engagement are defined in the applicable proposal and agreement. Compounded GLP-1 medications are not FDA-approved. The FDA has not reviewed compounded semaglutide, tirzepatide or other compounded GLP-1 products for safety, effectiveness or quality, and they are not equivalent to FDA-approved drugs. Information is accurate to the best of our knowledge at the time of writing. Medications, coverage rules and the news around them change quickly, and pages are not always updated the moment something changes. Views expressed by anyone other than GLP-1 Studio are their own. Their appearance here is not an endorsement, and it does not imply an affiliate, sponsorship or business relationship.